TG Therapeutics (TGTX) Reports Q3 Loss of $0.43

TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.43), versus ($0.48) reported last year.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Crocs upgraded to Overweight at Piper Sandler on North America recovery signs
• Farmmi announces public offering of Class A ordinary shares